Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 7Neoplasms 2Weight Loss 1Prostatic Neoplasms 1Polyps 1Osteoporosis 1Myocardial Ischemia 1Myocardial Infarction 1Metabolic Syndrome 1Heart Diseases 1Diabetes Mellitus 1Depression 1Coronary Disease 1Colonic Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Bone Diseases 1Body Weight Changes 1Angina, Unstable 1Adenoma 1

Interventions

Zoledronic Acid 14Vitamin D 8Risedronic Acid 8Letrozole 7Calcium 7Calcium Carbonate 5Absorptiometry, Photon 5Cholecalciferol 4Denosumab 3Alendronate 3bicalutamide 2Resistance Training 2Nutrition Assessment 2Kyphoplasty 2Hormone Replacement Therapy 2Calcium Gluconate 2Calcium Citrate 2Aromatase Inhibitors 2Anastrozole 2xian ling gu bao 1parathyroid hormone-related peptide (1-36) 1X-Rays 1Toremifene 1Technetium 1Raloxifene Hydrochloride 1Radiotherapy 1Progestins 1Lysine Acetyltransferase 5 1Linseed Oil 1Ibandronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Osteoporosis × Diet, Fat-Restricted × Clear all
NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡